CELGENE ANNOUNCES RETIREMENT OF EXECUTIVE CHAIRMAN BOB HUGIN AND APPOINTMENT OF CEO MARK ALLES AS CHAIRMAN OF THE BOARD OF DIRECTORS

Celgene announced that Executive Chairman Bob Hugin has decided to retire from Celgene after 19 years of service and to step down from the Celgene Board of Directors. Chief Executive Officer Mark Alles has been appointed to the additional role of Chairman of the Board of Directors. 

“Bob Hugin has contributed immeasurably to Celgene during his 19-year tenure. Under his stellar strategic leadership and guidance, Celgene has achieved unprecedented growth, produced extraordinary business results, and most importantly has developed and delivered transformational therapies for patients,” said Mark Alles, Chief Executive Officer of Celgene. 

Source: Celgene website

-